= LhARA Steering Group meeting !#3 = //**3^rd^ July 2020 10:00 GMT**// == Connection details == Please join ZOOM meeting at: **https://cern.zoom.us/j/96325392842?pwd=cnNGeWhGeHlsb09PY0tVTEYwWUdlUT09** == Agenda == 1. [wiki:Research/DesignStudy/SteeringGroup/2020-06-05 Notes of last meeting and actions arising:] * **KL**: Set up series of meetings with leads at partner organisations to discuss preparation of R&D programme. * **Ongoing.** Need to step up the priority of this activity as we prepare the EPSRC proposal. * **KL/CB**: Consider meeting between Imperial (and other) ion-accelerator experts with the relevant experts in CLF. * **Stands.** This meeting is necessary and, probably, should include Strathclyde and Belfast. * **KL/KK** to collaborate on the development for a proposal for such a meeting on the timescale of November 2020. * **Stands.** Agenda item. * **KL** Send out diary invitation straight away to get it into the diary. * **Done.** 2. [raw-attachment:2020-07-03-SGMeeting.pdf​ Project Managers report]: AK \\ 3. Discussion of SG composition: KL/All 4. [https://epsrc.ukri.org/funding/calls/second-call-for-transformative-healthcare-technologies-pre-announcement-and-engagement-event/ EPSRC Transformative Healthcare Technologies call]: KL/All * Dealing with feedback from our 2019 submission: \\ "//Engagement with patients, clinicians and industry could have been strengthened//" - Patient engagement: - Actions taken to date; - Need for local action by partner; - Subsequent coordination - Clinician engagement: - Actions taken to date; - Need for local action by partner; - Subsequent coordination - Industrial engagement: - Actions taken to date; - Discussion of next steps * Slides to initiate discussion of: - Scope; - Initial discussion of work packages; - Stakeholders from whom we should be seeking support; * Next steps discussion 5. Follow-up Discussion of dedicated advanced diagnostics and instrumentation for the //in vitro// and //in vivo// end stations: KL/all 6. DONMs \\ * 04 Sep 2020; 10:00 BST 7. AoB \\ ----